Skip to main content

Table 1 Patient characteristics and treatment plan

From: Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT

ID Sex/age Diagnosis Number of tumors treated Previous local treatment Σ CTV (cc) Liver-CTV (cc) Total dose (Gy)/fractions
1 M/59 IHC 1 67.7 2829.0 54/6
2 M/62 mCRC 1 16.1 1775.8 56.25/3
3 M/68 mCRC 1 RFA 6.3 3219.9 56.25/3
4 F/91 mCRC 1 44.1 1121.9 45/3
5 M/64 mCRC 3 RFA 25.0 2113.7 45/3
6 M/62 mCRC 2 Resection 1.2 1433.3 56.25/3
  1. M male, F female, IHC intrahepatic cholangiocarcinoma, mCRC metastatic colorectal cancer, RFA radiofrequency ablation, Σ sum, CTV clinical target volume, cc cubic centimeters, Gy gray